bicalutamide has been researched along with Hemolysis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rajput, SJ; Saroj, S | 1 |
| Belgamwar, VS; Dhas, NL; Ige, PP; Kudarha, R; Pandey, A | 1 |
2 other study(ies) available for bicalutamide and Hemolysis
| Article | Year |
|---|---|
Facile development, characterization, and evaluation of novel bicalutamide loaded pH-sensitive mesoporous silica nanoparticles for enhanced prostate cancer therapy.
Topics: Anilides; Antineoplastic Agents; Cell Line, Tumor; Drug Carriers; Drug Liberation; Drug Screening Assays, Antitumor; Hemolysis; Humans; Hydrogen-Ion Concentration; Male; Nanoparticles; Nitriles; Prostatic Neoplasms; Silicon Dioxide; Tosyl Compounds | 2019 |
Box-Behnken study design for optimization of bicalutamide-loaded nanostructured lipid carrier: stability assessment.
Topics: Androgen Antagonists; Anilides; Animals; Antineoplastic Agents; Blood Proteins; Drug Carriers; Drug Stability; Hemolysis; Lipids; Nanostructures; Nitriles; Particle Size; Rats; Tosyl Compounds | 2015 |